BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghidini M, Tomasello G, Botticelli A, Barni S, Zabbialini G, Seghezzi S, Passalacqua R, Braconi C, Petrelli F. Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis. HPB (Oxford). 2017;19:741-748. [PMID: 28684194 DOI: 10.1016/j.hpb.2017.05.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Deng YL, Li J. Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients. Ann Surg Oncol 2020;27:940-1. [PMID: 32989657 DOI: 10.1245/s10434-020-09167-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kamarajah SK, Bednar F, Cho CS, Nathan H. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis. Cancer 2021;127:1266-74. [PMID: 33320344 DOI: 10.1002/cncr.33356] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Dondossola D, Ghidini M, Grossi F, Rossi G, Foschi D. Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma. World J Gastroenterol 2020; 26(25): 3542-3561 [PMID: 32742125 DOI: 10.3748/wjg.v26.i25.3542] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Caparica R, Bruzzone M, Hachem GE, Ceppi M, Lambertini M, Glasberg J, de Azambuja E, Van Laethem JL, Hendlisz A. Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Oncol Hematol 2020;149:102940. [PMID: 32252001 DOI: 10.1016/j.critrevonc.2020.102940] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shroff RT, Kennedy EB, Bachini M, Bekaii-Saab T, Crane C, Edeline J, El-Khoueiry A, Feng M, Katz MHG, Primrose J, Soares HP, Valle J, Maithel SK. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. J Clin Oncol. 2019;37:1015-1027. [PMID: 30856044 DOI: 10.1200/jco.18.02178] [Cited by in Crossref: 113] [Cited by in F6Publishing: 47] [Article Influence: 37.7] [Reference Citation Analysis]
6 Ostwal V, Swami R, Patkar S, Majumdar S, Goel M, Mehta S, Engineer R, Mandavkar S, Kumar S, Ramaswamy A. Gemcitabine-cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward. Med Oncol 2018;35:57. [PMID: 29564657 DOI: 10.1007/s12032-018-1115-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kemp Bohan PM, Nelson DW. Reply to "Comment on: Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients". Ann Surg Oncol 2020;27:942-3. [PMID: 32978701 DOI: 10.1245/s10434-020-09170-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kim H, Heo MH, Kim JY. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer. BMC Gastroenterol 2020;20:20. [PMID: 31992208 DOI: 10.1186/s12876-020-1171-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Ma WJ, Jin YW, Wu ZR, Yang Q, Wang JK, Liu F, Shi YJ, Li QS, Cheng NS. Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers. HPB (Oxford) 2020;22:939-49. [PMID: 32349925 DOI: 10.1016/j.hpb.2020.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
10 Kaavya J, Mahalaxmi I, Devi SM, Santhy KS, Balachandar V. Targeting phosphoinositide-3-kinase pathway in biliary tract cancers: A remedial route? J Cell Physiol 2019;234:8259-73. [PMID: 30370571 DOI: 10.1002/jcp.27673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Wang ML, Ke ZY, Yin S, Liu CH, Huang Q. The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review. Hepatobiliary Pancreat Dis Int 2019;18:110-6. [PMID: 30470543 DOI: 10.1016/j.hbpd.2018.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
12 Søreide K, Harrison EM, Wigmore SJ. Research gaps and unanswered questions in gallbladder cancer. HPB 2018;20:685-6. [DOI: 10.1016/j.hpb.2018.03.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
13 Choi YH, Lee SH. Editorial on "A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery". Ann Transl Med 2020;8:522. [PMID: 32411745 DOI: 10.21037/atm.2020.03.182] [Reference Citation Analysis]
14 Yee NS. Update in Systemic and Targeted Therapies in Gastrointestinal Oncology. Biomedicines 2018;6:E34. [PMID: 29547556 DOI: 10.3390/biomedicines6010034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
15 Hickman L, Contreras C. Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies. Surg Clin North Am. 2019;99:337-355. [PMID: 30846038 DOI: 10.1016/j.suc.2018.12.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 12.7] [Reference Citation Analysis]
16 Li J, Zhou MH, Ma WJ, Li FY, Deng YL. Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring? World J Gastroenterol 2020; 26(24): 3318-3325 [PMID: 32655260 DOI: 10.3748/wjg.v26.i24.3318] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chen X, Meng F, Xiong H, Zou Y. Adjuvant Therapy for Resectable Biliary Tract Cancer: A Bayesian Network Analysis. Front Oncol 2021;11:600027. [PMID: 33777744 DOI: 10.3389/fonc.2021.600027] [Reference Citation Analysis]
18 Zhao YY, Chen SH, Wan QS. A prognostic nomogram for distal bile duct cancer from Surveillance, Epidemiology, and End Results (SEER) database based on the STROBE compliant. Medicine (Baltimore) 2019;98:e17903. [PMID: 31725638 DOI: 10.1097/MD.0000000000017903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Horgan AM, Knox JJ. Adjuvant Therapy for Biliary Tract Cancers. JOP 2018;14:701-8. [DOI: 10.1200/jop.18.00558] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
20 Roos E, Strijker M, Franken LC, Busch OR, van Hooft JE, Klümpen HJ, van Laarhoven HW, Wilmink JW, Verheij J, van Gulik TM, Besselink MG. Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center. HPB (Oxford) 2020;22:405-14. [PMID: 31494056 DOI: 10.1016/j.hpb.2019.07.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
21 Luvira V, Satitkarnmanee E, Pugkhem A, Kietpeerakool C, Lumbiganon P, Pattanittum P. Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma. Cochrane Database Syst Rev 2021;9:CD012814. [PMID: 34515993 DOI: 10.1002/14651858.CD012814.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Søreide K, Guest RV, Harrison EM, Kendall TJ, Garden OJ, Wigmore SJ. Systematic review of management of incidental gallbladder cancer after cholecystectomy. Br J Surg 2019;106:32-45. [PMID: 30582640 DOI: 10.1002/bjs.11035] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 12.0] [Reference Citation Analysis]
23 Kamarajah SK, Al-Rawashdeh W, White SA, Abu Hilal M, Salti GI, Dahdaleh FS. Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study. Eur J Surg Oncol 2021:S0748-7983(21)00724-1. [PMID: 34518052 DOI: 10.1016/j.ejso.2021.09.002] [Reference Citation Analysis]
24 Perego G, Burgio V, Nozza R, Longobardo G, Bernecich M, Luciani A, Petrelli F. Is there any place for novel agents in treating biliary tract cancer? Med Oncol 2021;38:19. [PMID: 33543377 DOI: 10.1007/s12032-021-01463-4] [Reference Citation Analysis]
25 Filippi R, Lombardi P, Quarà V, Fenocchio E, Aimar G, Milanesio M, Leone F, Aglietta M. Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives. Expert Opin Pharmacother 2019;20:2121-37. [PMID: 31550186 DOI: 10.1080/14656566.2019.1667335] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
26 Kish M, Chan K, Perry K, Ko YJ. A systematic review and network meta-analysis of adjuvant therapy for curatively resected biliary tract cancers. Curr Oncol 2020;27:e20-6. [PMID: 32218664 DOI: 10.3747/co.27.5465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Kamarajah SK, Al-Rawashdeh W, Parente A, Atherton P, Salti GI, Dahdaleh FS, Manas D, Hilal MA, White SA. Adjuvant chemotherapy for perihilar cholangiocarcinoma: A population-based comparative cohort study. Eur J Surg Oncol 2021:S0748-7983(21)00949-5. [PMID: 34916085 DOI: 10.1016/j.ejso.2021.12.002] [Reference Citation Analysis]
28 Massironi S, Pilla L, Elvevi A, Longarini R, Rossi RE, Bidoli P, Invernizzi P. New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma. Cells 2020;9:E688. [PMID: 32168869 DOI: 10.3390/cells9030688] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
29 Belkouz A, Wilmink JW, Haj Mohammad N, Hagendoorn J, de Vos-Geelen J, Dejong CHC, Homs MYV, Groot Koerkamp B, van Gulik TM, van Oijen MGH, Punt CJA, Klümpen H. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials. Crit Rev Oncol Hematol 2020;151:102975. [PMID: 32464483 DOI: 10.1016/j.critrevonc.2020.102975] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
30 Ghidini M, Pizzo C, Botticelli A, Hahne JC, Passalacqua R, Tomasello G, Petrelli F. Biliary tract cancer: current challenges and future prospects. Cancer Manag Res. 2019;11:379-388. [PMID: 30643463 DOI: 10.2147/cmar.s157156] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]